Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

XGN

Exagen (XGN)

Exagen Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:XGN
일자시간출처헤드라인심볼기업
2025/01/1322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
2025/01/1302:00GlobeNewswire Inc.Exagen Inc. Secures Conditional NY State Approval for New Lupus and Rheumatoid Arthritis Biomarkers and Announces Select Preliminary 2024 Financial ResultsNASDAQ:XGNExagen Inc
2024/12/1307:00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:XGNExagen Inc
2024/12/1223:00GlobeNewswire Inc.Exagen Inc. Achieves Key Milestone with 1,000,000th Patient Tested by AVISE® CTDNASDAQ:XGNExagen Inc
2024/11/2806:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/11/2009:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/11/1908:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/11/1506:30GlobeNewswire Inc.Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD PlatformNASDAQ:XGNExagen Inc
2024/11/1406:05GlobeNewswire Inc.Exagen Inc. to Participate in Fourth Quarter Investor ConferencesNASDAQ:XGNExagen Inc
2024/11/1222:00GlobeNewswire Inc.Exagen Inc. Reports Third Quarter 2024 ResultsNASDAQ:XGNExagen Inc
2024/10/3005:05GlobeNewswire Inc.Exagen to Announce Third Quarter 2024 Results on November 12, 2024NASDAQ:XGNExagen Inc
2024/10/2205:05GlobeNewswire Inc.Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology ConvergenceNASDAQ:XGNExagen Inc
2024/10/0905:39Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XGNExagen Inc
2024/09/0507:12Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/09/0507:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/09/0505:05GlobeNewswire Inc.Exagen Inc. to Participate in the 2024 Cantor Global Healthcare ConferenceNASDAQ:XGNExagen Inc
2024/08/1006:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:XGNExagen Inc
2024/08/0522:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:XGNExagen Inc
2024/08/0521:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
2024/08/0521:00GlobeNewswire Inc.Exagen Inc. Reports Strong Second Quarter 2024 Results: Raises Guidance due to Record PerformanceNASDAQ:XGNExagen Inc
2024/08/0306:20Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:XGNExagen Inc
2024/08/0222:00GlobeNewswire Inc.Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth ConferenceNASDAQ:XGNExagen Inc
2024/08/0221:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
2024/08/0122:00GlobeNewswire Inc.Exagen Appoints Jeffrey G. Black as New Chief Financial OfficerNASDAQ:XGNExagen Inc
2024/07/2222:00GlobeNewswire Inc.Exagen to Announce Second Quarter 2024 Results on August 5, 2024NASDAQ:XGNExagen Inc
2024/06/1305:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/06/1305:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/06/1305:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
2024/06/1205:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:XGNExagen Inc
2024/05/1709:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XGNExagen Inc
 검색 관련기사 보기:NASDAQ:XGN